ANSWER: This common problem is called solar purpura, and it is largely the sun causing the damage to the skin, thinning it ...

Special to IFN Iredell Physician Network and Iredell Health System are excited to announce the opening of Iredell Ear, Nose & ...

Sinus-related dizziness (described as lightheadedness, faintness, or loss of balance) is a fairly common problem experienced with sinus infections, allergies, or other issues like nasal polyps. Sinus ...

Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) mainly expresses type-2 endotype, featuring eosinophils as a main player in the inflammatory process. Prolonged eosinophilia in the tissues of ...

1. In this randomized controlled trial, among patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, tezepelumab more effectively reduced nasal polyp size and sinonasal symptoms ...

Ear, nose and throat (ENT) specialist surgeon Dr Winile Makhaye, explains to TRUELOVE that sinusitis, or swelling of the tissues in your sinuses, “can eventually cause what you call polyps ... Winile ...

While most nasal polyps are benign, contact a healthcare provider for any ... Sinus infection basics. MedlinePlus. Allergic rhinitis. Alghamdi FS, Albogami D, Alsurayhi AS, et al. Nasal septal ...

SAN DIEGO — Among patients with previous sinus surgery for chronic rhinosinusitis with nasal polyps, the number of past surgeries did not alter the benefits of mepolizumab on nasal polyp and VAS ...

SAN DIEGO — Among patients with previous sinus surgery for chronic rhinosinusitis with nasal polyps, the number of past surgeries did not alter the benefits of mepolizumab on nasal polyp and VAS ...

Three new drug applications of Stapokibart for the treatment of moderate-to-severe atopic dermatitis (AD) in adults, chronic rhinosinusitis with nasal polyposis (CRSwNP) and seasonal allergic rhinitis ...

Tezepelumab is an epithelial cytokine blocker used to treat severe asthma; its efficacy and safety in patients with chronic rhinosinusitis with nasal polyps have been unclear. New research ...